Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Synlogic Inc.
Sponsor

Synlogic Inc.

United States 301 Binney Street Suite 402, 02142-1071, United States

About the sponsor

Synlogic Inc. focuses its clinical research on phenylketonuria (PKU), a metabolic disorder associated with elevated phenylalanine levels and the need for long-term biochemical control.

  • Blood phenylalanine management
  • Metabolic disease treatment
  • Amino acid regulation

The sponsor’s research activity is centered on therapies intended to address the clinical burden of PKU through targeted metabolic intervention and assessment of tolerability.

About Specializations

Synlogic Inc. runs clinical trials in conditions such as Phenylketonuria, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Phenylketonuria

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Esomeprazole
  • Sponsor:Synlogic Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.